Levelpath vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Levelpath

EmergingEnterprise SaaS

AI-Native Procurement Platform

Raised $55M+ Series B (Jun 2025) led by Battery Ventures. $100M total. Proprietary Hyperbridge reasoning engine. Battery partner Neeraj Agrawal (backed Coupa to $8B) leads the board.

About

Levelpath is an AI-native enterprise procurement platform with a proprietary "Hyperbridge" reasoning engine — purpose-built for procurement AI rather than a wrapper on generic LLMs. The company raised $55 million+ in Series B financing in June 2025, led by Battery Ventures (with Redpoint and Benchmark as co-investors), bringing total funding to $100 million. Battery partner Neeraj Agrawal, who led Battery's investment in Coupa (which sold to Vista Equity for $8 billion), leads the Levelpath board.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.